Sarcoptes scabiei var. suis (Sarcoptic Mange)
LEVELS: Highly unlikely: No controls necessary; Highly unlikely: No evidence of non-foodborne zoonotic transmission; Highly effective: Routine on-farm biosecurity measures are effective in preventing farm-to-farm transmission; Moderate: Clinical signs not unique but existing tests available at local/regional laboratory(s); Substantial: Unsustainable acute or chronic losses related to severe clinical signs in a high prevalence of animals; Negligible: Little or no market disruption when disease occurs on one or more farms; Minimal risk: Agent inherently unlikely to develop clinically important resistance to antibacterial or antiviral treatments; Minimal risk: Antibacterial or antiviral treatments rarely occur, or are typically limited to short-course individual animal therapy; Widely available: Multiple effective treatments widely available in the US; Available but uncertain efficacy: Commercial or autogenous vaccines exist in the US but protection may be inconsistent; Highly likely: Can be eradicated using existing tools and knowledge
Criteria Levels
- Foodborne Zoonotic Transmission: No evidence of transmission
- Non-Foodborne Zoonotic Transmission: Rare transmission events
- Beyond-Farm Spread Potential: Farm biosecurity effective
- Detection Difficulty: Moderate: confirmation once suspected
- Financial Impact - Mortality and Morbidity Costs: Substantial ongoing losses
- Financial Impact - Prevention and Control Costs: Little market disruption
- Antimicrobial Resistance - Pathogen Risk: Low resistance risk
- Antimicrobial Resistance - Treatment Impact: Minimal: Rare or short-course individual treatments
- Treatment Availability: Multiple effective treatments
- Vaccine Availability: Effective vaccines available but with limitations
- Eradication Feasibility: Can be eradicated using existing tools and knowledge
Overview
Sarcoptic mange (scabies, sarcoptosis) is the most important ectoparasite of swine worldwide. Caused by the burrowing mite Sarcoptes scabiei var. suis, it produces two clinical forms: a chronic hyperkeratotic form in sows and a pruritic hypersensitive form in growing pigs. Historical prevalence has been high (40-90% of herds in some locales), though many modern production systems have successfully eliminated the parasite. The economic impact includes reduced growth rates (4.5-12%), reduced feed efficiency, decreased fertility in breeding sows, and carcass downgrading at slaughter.
Detailed Justification
1. Foodborne Zoonotic Transmission
Level: No evidence of transmission
Sarcoptic mange mites are not transmitted through food. The parasite is an obligate skin parasite that does not enter the food chain. There is no mechanism for foodborne transmission to humans.
2. Non-Foodborne Zoonotic Transmission
Level: Rare transmission events
S. scabiei var. suis is host-adapted to swine and shows high host specificity. The chapter states that humans who handle infested pigs can act as "mechanical vectors for the mites," and workers must change clothes and shower before moving between herds. While transient human infestation can occur, the mite does not establish sustained infection in humans - it causes temporary irritation but cannot complete its life cycle on human hosts. This represents rare, self-limiting transmission.
3. Beyond-Farm Spread Potential
Level: Farm biosecurity effective
The mite is highly host-specific and survives poorly away from the pig: - "Under field conditions, survival off of the host is poor, usually no more than 3 days" - "Viability is reduced by desiccation, sunlight, heat, and extreme cold" - "The source of mites is other swine"
Standard biosecurity measures focusing on animal introduction are effective: - "All animals introduced into the herd must be treated before coming into the herd" - "Biosecurity measures that focus on careful scrutiny of a minimal number of sources of incoming stock are usually adequate to prevent the introduction of the parasite"
4. Detection Difficulty
Level: Moderate: confirmation once suspected
Clinical suspicion is straightforward when pruritus and skin lesions are present, but confirmation requires effort: - "Finding the mites by means of skin scrapings confirms the diagnosis, but burrowing of mites reduces the sensitivity of this diagnostic method" - "The majority of pigs in an infested herd may be subclinical and may not manifest pruritus" - Multiple techniques described for mite detection (KOH maceration, incubation, microscopy)
ELISA testing available with "individual sensitivity varies from 29 to 64%, but as a herd test, sensitivity approaches 95%." This indicates moderate difficulty - clinical signs suggest the diagnosis but definitive confirmation requires specialized techniques.
5. Financial Impact - Mortality and Morbidity Costs
Level: Substantial ongoing losses
The chapter documents significant production impacts: - "Herds infested with scabies suffer reduced growth rates, reduced feed efficiency, and decreased fertility in breeding sows" - "The most significant effect of sarcoptic mange is reduced growth rate (4.5-12%) and feed efficiency in growing pigs" - "The real economic importance tends to be underestimated because pork producers may not recognize the presence of scabies"
This represents ongoing, herd-wide production losses rather than sporadic individual animal losses.
6. Financial Impact - Prevention and Control Costs
Level: Little market disruption
Sarcoptic mange is not a regulated disease. While there are economic effects from "downgrading and trimming of carcasses at slaughter, as well as damage to pens and fixtures caused by rubbing pigs," there are no trade restrictions, export bans, or market access issues. The financial impact is limited to direct production losses and treatment costs.
7. Antimicrobial Resistance - Pathogen Risk
Level: Low resistance risk
Sarcoptic mange is treated with acaricides, not antimicrobials. The mite is an arthropod parasite, so antimicrobial resistance in the traditional sense does not apply. While acaricide resistance could theoretically develop, this is not an AMR concern relevant to the One Health framework.
8. Antimicrobial Resistance - Treatment Impact
Level: Minimal: Rare or short-course individual treatments
Treatment involves acaricides (avermectins, amitraz, phosmet), not antibiotics. There is no antimicrobial selection pressure from mange treatment. The criterion does not apply in the traditional AMR sense.
9. Treatment Availability
Level: Multiple effective treatments
Highly effective treatments are available: - "The large majority of registered products will keep scabies under control and some even eradicate it" - "More modern acaricides are safer, have higher efficacies, and are easier to administer" - Effective products include avermectins (ivermectin, doramectin, moxidectin), amitraz, and phosmet - "Current products are more efficient because of their systemic action and ease of administration"
10. Vaccine Availability
Level: Effective vaccines available but with limitations
No vaccine exists for sarcoptic mange. However, this criterion doesn't fit well for ectoparasites. The "limitation" here is that prevention relies entirely on acaricide treatment and management rather than immunization. Given that highly effective chemical control exists and eradication programs are successful, I'm selecting this level to reflect that prophylactic tools exist but are not vaccines per se.
Note: If a "No vaccine" level is more appropriate for parasites where vaccination isn't applicable, this should be reconsidered.
11. Eradication Feasibility
Level: Can be eradicated using existing tools and knowledge
The chapter strongly supports eradication feasibility: - "Many modern production systems and seed-stock suppliers have been successful in eliminating scabies" - "Mange-free herds can be established with cesarean-derived pigs, by depopulation and repopulation from mange-free stock, by segregated rearing of treated pigs, and by eradication using avermectins" - "In a number of countries, major breeding-stock suppliers maintain mange-free herds, and large populations of pigs in integrated production systems have been kept free of the parasite for many years" - "Eradication of sarcoptic mange is possible with a variety of programs developed around the use of effective acaricides"
Summary
Sarcoptes scabiei var. suis causes the most economically important ectoparasitic disease of swine worldwide. The mite is highly host-specific, surviving poorly off the pig, which facilitates control and eradication. Two clinical forms exist: hyperkeratotic mange in adult swine (primarily sows) and hypersensitive/pruritic mange in growing pigs. Economic losses stem from reduced growth rates (4.5-12%), decreased feed efficiency, impaired fertility, and carcass downgrading. Diagnosis requires demonstration of mites in skin scrapings or ELISA serology. Multiple highly effective acaricides are available, and eradication has been achieved in many modern production systems through treatment protocols, biosecurity, and all-in/all-out management. This should be the goal for most farms.